CD28, CTLA‐4 and their ligands: who does what and to whom?
Open accessThe DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
T-cell activation is a critical event in the organization of effective cellular and humoral immune responses. Activated T cells are essential for provision of T-cell help, promoting the development of high-affinity antibody production and the generation of cytotoxic T-cell responses. Accordingly, defects in proteins required for T-cell activation give rise to significant infectious pathology and malignancies. However, the decision to allow T-cell activation also has potentially dangerous consequences for the host and must therefore also be tightly controlled. Defects in proteins involved in regulating activated T-cell behaviour therefore tend to lead to autoimmunity. Thus, the major challenge faced in regulating T-cell responses is how to maintain a sufficiently large immune repertoire capable of recognizing all possible foreign antigens, whilst at the same time maintaining T cells in an unresponsive state towards self-antigens. In recent years significant progress has been made in our understanding of the mechanisms of self-tolerance. In the thymus it is clear that large numbers of potentially 'self-reactive' T cells are eliminated during negative selection in a process termed central tolerance. However, paradoxically, the process of positive selection that permits the expansion of T cells with low avidity for self–major histocompatibility complex (MHC) interactions must also lead to a degree of self-reactivity which is presumably tolerable in peripheral T cells. The question is how such T cells (albeit weakly self-reactive) can be ensured to remain non-reactive amongst a different array of self-antigens in the periphery. In the last few years a number of proteins have been identified that may serve the function of 'quality controlling' peripheral T-cell activation. This review focuses on two proteins, CD28 and cytotoxic T lymphocyte antigen-4 (CTLA-4), and explores how their interactions with their natural ligands may regulate the outcome of T-cell receptor engagement amongst peripheral T cells. CD28 and CTLA-4 (CD152) are transmembrane protein members of the immunoglobulin gene superfamily containing a single extracellular 'V-like' domain. 1–3 Both proteins are predominantly expressed by T cells and whilst CD28 is found in substantial amounts on the cell surface of the majority of resting T cells, in contrast CTLA-4 surface expression is much more limited. 4 The levels of CTLA-4 expression in most resting T cells are extremely low (or probably absent), and CTLA-4 predominantly appears following T-cell activation. However, despite maximal expression being reported at 48–72 hr post-activation, remarkably little stable surface CTLA-4 is found, although mRNA is equivalent to that of CD28.5,6 This lower level of cell-surface expression results from a motif in the cytoplasmic domain of CTLA-4 that facilitates its interaction with the clathrin pit adaptor complex (AP-50) causing its rapid internalization from the cell surface. 7–9 Consequently the majority of CTLA-4 is found in intracellular vesicles that may be then targeted to the cell surface at the site of T-cell receptor (TCR) contact. 10 It has been suggested that phosphorylation of the CTLA-4 cytoplasmic domain results in disengagement from the AP-50 internalization system and therefore stabilizes cell-surface expression. 8 The complexity of the CD28/CTLA-4 receptor interactions stems from the fact that there are two natural ligands CD80 (B7-1) and CD86 (B7-2) for these receptors. 11–17 Whilst these ligands can both interact with either receptor, they are only approximately 25% identical in sequence and it has therefore been attractive to speculate that they may serve different functions. Predictably, for co-stimulatory ligands, CD80 and CD86 are found on professional antigen-presenting cells such as dendritic cells, monocytes and activated B cells, although they can be induced on other cell types including T cells. 13,17–21 In general CD86 is the more abundant in terms of expression, and is increased more rapidly upon activation. In contrast CD80 is not generally found on resting antigen-presenting cells (APCs) and is induced more slowly upon cellular activation. A large variety of stimuli have been investigated in the control of CD80 and CD86 expression. Most of these, such as CD40, interferon-γ (IFN-γ), interferon-α (IFN-α), granulocyte–macrophage colony-stimulating factor (GM-CSF) and lipopolysaccharide (LPS) appear to result in increased expression 18,22–27 whereas others such as interlekin-10 (IL-10) and interleukin-4 (IL-4) may inhibit expression. 28–30 These expression studies, together with findings in CD80 and CD86 KO mice, 31–33 tend to indicate that CD86 is probably the major initial ligand for CD28 during T-cell activation, based mainly on its more rapid and abundant expression on APCs. However, functional data indicate that CD80 is probably the more potent CD28 ligand in terms of activation,34,35 which is consistent with affinity measuremen
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
Krummel, M. F., & Allison, J. P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.459 · Cited by 2,245
Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
Read, S., Malmström, V., & Powrie, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,205
Salomon, B., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., & Bluestone, J. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80195-8 · Cited by 2,081
A cell culture model for T lymphocyte clonal anergy
Schwartz, R. H. (1990) · Science · doi:10.1126/science.2113314 · Cited by 1,857
CTLA-4 is a second receptor for the B cell activation antigen B7.
Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.561 · Cited by 1,685
Kuchroo, V. K., Prabhu Das, M., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N., & Glimcher, L. H. (1995) · Cell · doi:10.1016/0092-8674(95)90349-6 · Cited by 1,641
Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H., & Allison, J. P. (1992) · Nature · doi:10.1038/356607a0 · Cited by 1,559
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
Larsen, C. P., Elwood, E. T., Alexander, D. Z., Ritchie, S. C., Hendrix, R., Tucker-Burden, C., Cho, H. R., Aruffo, A., Hollenbaugh, D., Linsley, P. S., et al. (1996) · Nature · doi:10.1038/381434a0 · Cited by 1,455
A new member of the immunoglobulin superfamily—CTLA-4
Brunet, J.-F., Denizot, F., Luciani, M.-F., Roux-Dosseto, M., Suzan, M., Mattei, M.-G., & Golstein, P. (1987) · Nature · doi:10.1038/328267a0 · Cited by 1,306
The Role of the CD28 Receptor During T Cell Responses to Antigen
Linsley, P. S., & Ledbetter, J. A. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001203 · Cited by 1,298
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257
Regulatory T Cells in Autoimmmunity
Shevach, E. M. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.423 · Cited by 1,236
Itoh, M., Takahashi, T., Sakaguchi, N., Kuniyasu, Y., Shimizu, J., Otsuka, F., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5317 · Cited by 1,211
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
Boise, L. H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (1995) · Immunity · doi:10.1016/1074-7613(95)90161-2 · Cited by 1,210
Jenkins, M. K., & Schwartz, R. H. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.2.302 · Cited by 1,170
Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.721 · Cited by 1,127
Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg
Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S., & Bluestone, J. A. (1992) · Science · doi:10.1126/science.1323143 · Cited by 1,121
T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds
Viola, A., & Lanzavecchia, A. (1996) · Science · doi:10.1126/science.273.5271.104 · Cited by 1,023
Linsley, P. S., Greene, J. L., Brady, W., Bajorath, J., Ledbetter, J. A., & Peach, R. (1994) · Immunity · doi:10.1016/s1074-7613(94)80021-9 · Cited by 980
T Lymphocyte Costimulation Mediated by Reorganization of Membrane Microdomains
Viola, A., Schroeder, S., Sakakibara, Y., & Lanzavecchia, A. (1999) · Science · doi:10.1126/science.283.5402.680 · Cited by 938
Krummel, M. F., & Allison, J. P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2533 · Cited by 932
B70 antigen is a second ligand for CTLA-4 and CD28
Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J. H., Lanier, L. L., & Somoza, C. (1993) · Nature · doi:10.1038/366076a0 · Cited by 909
The Duration of Antigenic Stimulation Determines the Fate of Naive and Effector T Cells
Iezzi, G., Karjalainen, K., & Lanzavecchia, A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80461-6 · Cited by 908
Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation
Freeman, G. J., Gribben, J. G., Boussiotis, V. A., Ng, J. W., Restivo, V. A., Lombard, L. A., Gray, G. S., & Nadler, L. M. (1993) · Science · doi:10.1126/science.7694363 · Cited by 902
Ding, L., Linsley, P. S., Huang, L. Y., Germain, R. N., & Shevach, E. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1224 · Cited by 829
CTLA-4 ligation blocks CD28-dependent T cell activation.
Walunas, T. L., Bakker, C. Y., & Bluestone, J. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2541 · Cited by 801
Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system.
Aruffo, A., & Seed, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8573 · Cited by 784
T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.
Linsley, P. S., Clark, E. A., & Ledbetter, J. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5031 · Cited by 747
Induction of Peripheral T Cell Tolerance In Vivo Requires CTLA-4 Engagement
Perez, V. L., Van Parijs, L., Biuckians, A., Zheng, X. X., Strom, T. B., & Abbas, A. K. (1997) · Immunity · doi:10.1016/s1074-7613(00)80284-8 · Cited by 716
Molecular Basis of T Cell Inactivation by CTLA-4
Lee, K.-M., Chuang, E., Griffin, M., Khattri, R., Hong, D. K., Zhang, W., Straus, D., Samelson, L. E., Thompson, C. B., & Bluestone, J. A. (1998) · Science · doi:10.1126/science.282.5397.2263 · Cited by 684
A Receptor/Cytoskeletal Movement Triggered by Costimulation During T Cell Activation
Wülfing, C., & Davis, M. M. (1998) · Science · doi:10.1126/science.282.5397.2266 · Cited by 610
Intracellular Trafficking of CTLA-4 and Focal Localization Towards Sites of TCR Engagement
Linsley, P. S., Bradshaw, J., Greene, J., Peach, R., Bennett, K. L., & Mittler, R. S. (1996) · Immunity · doi:10.1016/s1074-7613(00)80480-x · Cited by 609
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris
Abrams, J. R., Lebwohl, M. G., Guzzo, C. A., Jegasothy, B. V., Goldfarb, M. T., Goffe, B. S., Menter, A., Lowe, N. J., Krueger, G., Brown, M. J., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5857 · Cited by 597
Inaba, K., Witmer-Pack, M., Inaba, M., Hathcock, K. S., Sakuta, H., Azuma, M., Yagita, H., Okumura, K., Linsley, P. S., Ikehara, S., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1849 · Cited by 592
Lenschow, D. J., Ho, S. C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K. C., & Bluestone, J. A. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1145 · Cited by 583
CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells
Jenkins, M. K., Taylor, P. S., Norton, S. D., & Urdahl, K. B. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2461 · Cited by 562
Freeman, G. J., Boussiotis, V. A., Anumanthan, A., Bernstein, G. M., Ke, X.-Y., Rennert, P. D., Gray, G. S., Grlbben, J. G., & Nadler, L. M. (1995) · Immunity · doi:10.1016/1074-7613(95)90032-2 · Cited by 561
CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast Kinetics
van der Merwe, P. A., Bodian, D. L., Daenke, S., Linsley, P., & Davis, S. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.393 · Cited by 551
Regulation of T Cell Receptor Signaling by Tyrosine Phosphatase SYP Association with CTLA-4
Marengère, L. E. M., Waterhouse, P., Duncan, G. S., Mittrücker, H.-W., Feng, G.-S., & Mak, T. W. (1996) · Science · doi:10.1126/science.272.5265.1170 · Cited by 551
Identification of an Alternative CTLA-4 Ligand Costimulatory for T Cell Activation
Hathcock, K. S., Laszlo, G., Dickler, H. B., Bradshaw, J., Linsley, P., & Hodes, R. J. (1993) · Science · doi:10.1126/science.7694361 · Cited by 517
Borriello, F., Sethna, M. P., Boyd, S. D., Schweitzer, A. N., Tivol, E. A., Jacoby, D., Strom, T. B., Simpson, E. M., Freeman, G. J., & Sharpe, A. H. (1997) · Immunity · doi:10.1016/s1074-7613(00)80333-7 · Cited by 498
Lanier, L. L., O'Fallon, S., Somoza, C., Phillips, J. H., Linsley, P. S., Okumura, K., Ito, D., & Azuma, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.97 · Cited by 480
B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells.
Freeman, G. J., Freedman, A. S., Segil, J. M., Lee, G., Whitman, J. F., & Nadler, L. M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.8.2714 · Cited by 476
Gimmi, C. D., Freeman, G. J., Gribben, J. G., Sugita, K., Freedman, A. S., Morimoto, C., & Nadler, L. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6575 · Cited by 427
CTLA-4-Mediated Inhibition of Early Events of T Cell Proliferation
Brunner, M. C., Chambers, C. A., Chan, F. K.-M., Hanke, J., Winoto, A., & Allison, J. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5813 · Cited by 419
Chambers, C. A., Sullivan, T. J., & Allison, J. P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80406-9 · Cited by 411
Absence of B7-dependent responses in CD28-deficient mice
Green, J. M., Noel, P. J., Sperling, A. I., Walunas, T. L., Gray, G. S., Bluestone, J. A., & Thompson, C. B. (1994) · Immunity · doi:10.1016/1074-7613(94)90092-2 · Cited by 376
CD28/B7 Regulation of Th1 and Th2 Subsets in the Development of Autoimmune Diabetes
Lenschow, D. J., Herold, K. C., Rhee, L., Patel, B., Koons, A., Qin, H.-Y., Fuchs, E., Singh, B., Thompson, C. B., & Bluestone, J. A. (1996) · Immunity · doi:10.1016/s1074-7613(00)80323-4 · Cited by 374
Larsen, C. P., Ritchie, S. C., Hendrix, R., Linsley, P. S., Hathcock, K. S., Hodes, R. J., Lowry, R. P., & Pearson, T. C. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.11.5208 · Cited by 367
Chen, W., Jin, W., & Wahl, S. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1849 · Cited by 352
Liu, Y.-J., Barthélémy, C., Bouteiller, O. D., Arpin, C., Isabelle, D., & Banchereau, J. (1995) · Immunity · doi:10.1016/1074-7613(95)90048-9 · Cited by 347
Shiratori, T., Miyatake, S., Ohno, H., Nakaseko, C., Isono, K., Bonifacino, J. S., & Saito, T. (1997) · Immunity · doi:10.1016/s1074-7613(00)80346-5 · Cited by 345
Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells
Lo, D., Burkly, L. C., Widera, G., Cowing, C., Flavell, R. A., Palmiter, R. D., & Brinster, R. L. (1988) · Cell · doi:10.1016/0092-8674(88)90497-7 · Cited by 340
Regulation of surface and intracellular expression of CTLA4 on mouse T cells
Alegre, M. L., Noel, P. J., Eisfelder, B. J., Chuang, E., Clark, M. R., Reiner, S. L., & Thompson, C. B. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.4762 · Cited by 338
Freedman, A. S., Freeman, G. J., Rhynhart, K., & Nadler, L. M. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90091-o · Cited by 312
Jenkins, M. K., Pardoll, D. M., Mizuguchi, J., Chused, T. M., & Schwartz, R. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5409 · Cited by 298
CD28 costimulation promotes the production of Th2 cytokines
Rulifson, I. C., Sperling, A. I., Fields, P. E., Fitch, F. W., & Bluestone, J. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.658 · Cited by 291
Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes
Lühder, F., Höglund, P., Allison, J. P., Benoist, C., & Mathis, D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.3.427 · Cited by 290
Walker, L. S. K., Gulbranson-Judge, A., Flynn, S., Brocker, T., Raykundalia, C., Goodall, M., Förster, R., Lipp, M., & Lane, P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.8.1115 · Cited by 276
Buelens, C., Willems, F., Delvaux, A., Piérard, G., Delville, J., Velu, T., & Goldman, M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250940 · Cited by 274
Jenkins, M. K., Ashwell, J. D., & Schwartz, R. H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.10.3324 · Cited by 258
Regulatory T cells and inflammatory bowel disease
Groux, H., & Powrie, F. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01510-8 · Cited by 258
Structural Analysis of CTLA-4 Function In Vivo
Masteller, E. L., Chuang, E., Mullen, A. C., Reiner, S. L., & Thompson, C. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5319 · Cited by 252
Structure and Dimerization of a Soluble Form of B7-1
Ikemizu, S., Gilbert, R. J. C., Fennelly, J. A., Collins, A. V., Harlos, K., Jones, E. Y., Stuart, D. I., & Davis, S. J. (2000) · Immunity · doi:10.1016/s1074-7613(00)80158-2 · Cited by 249
Cutting Edge: Lymphoproliferative Disease in the Absence of CTLA-4 Is Not T Cell Autonomous
Bachmann, M. F., Köhler, G., Ecabert, B., Mak, T. W., & Kopf, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1128 · Cited by 235
Chuang, E., Alegre, M. L., Duckett, C. S., Noel, P. J., Vander Heiden, M. G., & Thompson, C. B. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.144 · Cited by 225
Schweitzer, A. N., & Sharpe, A. H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2762 · Cited by 211
Sperling, A. I., Auger, J. A., Ehst, B. D., Rulifson, I. C., Thompson, C. B., & Bluestone, J. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.9.3909 · Cited by 210
Razi-Wolf, Z., Freeman, G. J., Galvin, F., Benacerraf, B., Nadler, L., & Reiser, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4210 · Cited by 210
Judge, T. A., Wu, Z., Zheng, X.-G., Sharpe, A. H., Sayegh, M. H., & Turka, L. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.1947 · Cited by 204
Fallarino, F., Fields, P. E., & Gajewski, T. F. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.205 · Cited by 186
Tivol, E. A., Boyd, S. D., McKeon, S., Borriello, F., Nickerson, P., Strom, T. B., & Sharpe, A. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5091 · Cited by 185
Khattri, R., Auger, J. A., Griffin, M. D., Sharpe, A. H., & Bluestone, J. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5784 · Cited by 182
Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein
Zhang, Y., & Allison, J. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9273 · Cited by 181
Zheng, X. X., Markees, T. G., Hancock, W. W., Li, Y., Greiner, D. L., Li, X. C., Mordes, J. P., Sayegh, M. H., Rossini, A. A., & Strom, T. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4983 · Cited by 175
Schweitzer, A. N., Borriello, F., Wong, R. C., Abbas, A. K., & Sharpe, A. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2713 · Cited by 168
CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells.
Schneider, H., Prasad, K. V., Shoelson, S. E., & Rudd, C. E. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.351 · Cited by 165
Freeman, G. J., Lombard, D. B., Gimmi, C. D., Brod, S. A., Lee, K., Laning, J. C., Hafler, D. A., Dorf, M. E., Gray, G. S., & Reiser, H. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.12.3795 · Cited by 150
CD28: a signalling perspective
WARD, S. G. (1996) · Biochemical Journal · doi:10.1042/bj3180361 · Cited by 149
Mandelbrot, D. A., McAdam, A. J., & Sharpe, A. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.435 · Cited by 142
Reiser, H., Freeman, G. J., Razi-Wolf, Z., Gimmi, C. D., D, B. B. M., & Nadler, L. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.271 · Cited by 128
IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2.
Stack, R. M., Lenschow, D. J., Gray, G. S., Bluestone, J. A., & Fitch, F. W. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.12.5723 · Cited by 119
Radvanyi, Banerjee, Weir, & Messner (1999) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1999.00625.x · Cited by 118
Chambers, C. A., Kuhns, M. S., & Allison, J. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8603 · Cited by 116
Sayegh, M. H., Zheng, X.-G., Magee, C., Hancock, W. W., & Turka, L. A. (1997) · Transplantation · doi:10.1097/00007890-199712270-00003 · Cited by 114
B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro
Sansom, D. M., & Hall, N. D. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230148 · Cited by 110
Self-citationNakaseko, C., Miyatake, S., Iida, T., Hara, S., Abe, R., Ohno, H., & Saito, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.6.765 · Cited by 94
The Inhibitory Function of CTLA-4 Does Not Require Its Tyrosine Phosphorylation
Baroja, M. L., Luxenberg, D. P., Chau, T. A., Ling, V., Strathdee, C. A., Carreno, B. M., & Madrenas, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.49 · Cited by 90
CTLA-4 Ligation Suppresses CD28-induced NF-κB and AP-1 Activity in Mouse T Cell Blasts
Olsson, C., Riebeck, K., Dohlsten, M., & Michaëlsson, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.14400 · Cited by 84
Mittrücker, H., Shahinian, A., Bouchard, D., Kündig, T. M., & Mak, T. W. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2481 · Cited by 82
Fields, P. E., Finch, R. J., Gray, G. S., Zollner, R. S., Thomas, J. L., Sturmhöfel, K., Lee, K., Wolf, S. F., Gajewski, T. F., & Fitch, F. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5268 · Cited by 80
A negative regulatory function of B7 revealed in B7-1 transgenic mice
Sethna, M. P., van Perijs, L., Sharpe, A. H., Abbas, A. K., & Freemant, G. J. (1994) · Immunity · doi:10.1016/1074-7613(94)90072-8 · Cited by 78
Normal Responsiveness of CTLA-4-Deficient Anti-Viral Cytotoxic T Cells
Bachmann, M. F., Waterhouse, P., Speiser, D. E., McKall-Faienza, K., Mak, T. W., & Ohashi, P. S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.95 · Cited by 72
Waterhouse, P., Bachmann, M. F., Penninger, J. M., Ohashi, P. S., & Mak, T. W. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270811 · Cited by 72
McLeod, J., Walker, L. S. K., Patel, Y. I., Boulougouris, G., & Sansom, D. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2072 · Cited by 71
Self-citationThe Role of B7 Costimulation in CD4/CD8 T Cell Homeostasis
Xiang, Y., Fournier, S., Allison, J. P., Sharpe, A. H., & Hodes, R. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3543 · Cited by 69
Dahl, A. M., Klein, C., Andres, P. G., London, C. A., Lodge, M. P., Mulligan, R. C., & Abbas, A. K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.12.2031 · Cited by 59
Is CTLA-4 a negative regulator for T-cell activation?
Liu, Y. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01170-5 · Cited by 49
Lane, P. J. L., Haller, C., & McConnell, F. M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260420 · Cited by 29
Olsson, C., Michaëlsson, E., Parra, E., Pettersson, U., Lando, P. A., & Dohlsten, M. (1998) · International Immunology · doi:10.1093/intimm/10.4.499 · Cited by 29
Mutual Regulation Between B7-1 (CD80) Expressed on T Cells and IL-4
Schweitzer, A., & Sharpe, A. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4819 · Cited by 15
Regulation of fucosyltransferase-VII expression in peripheral lymph node high endothelial venules
(1998) · doi:10.1002/(sici)1521-4141(199810)28:10
Cited by
Orecchioni, M., Ghosheh, Y., Pramod, A. B., & Ley, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01084 · Cited by 2,063
Sharpe, A. H., & Freeman, G. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri727 · Cited by 1,712
The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses
Walker, L. S. K., & Sansom, D. M. (2011) · Nature Reviews Immunology · doi:10.1038/nri3108 · Cited by 786
Self-citationThe PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
Bardhan, K., Anagnostou, T., & Boussiotis, V. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00550 · Cited by 606
Immune Checkpoint Inhibitors: Basics and Challenges
Li, B., Chan, H. L., & Chen, P. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666170804143706 · Cited by 480
Metadata
- Authors
- Sansom, D. M.
- Venue
- Immunology
- Publisher
- Wiley
- Published
- 2000-10
- Volume
- 101
- Issue
- 2
- Pages
- 169-177
- ISSN
- 0019-2805 (ISSN-L)
- 1365-2567
- OpenAlex
- W1977818265
- Cited by
- 362
- References
- 108
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.